Loading data
PHARNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 45.5 m USD | 35.4 m USD | 25.21 m USD | 17.56 m USD | 21.14 m USD |
| Gross profit | 330.63 m USD | 261.8 m USD | 220.1 m USD | 188.06 m USD | 177.73 m USD |
| Research and development expense | 100.4 m USD | 83.1 m USD | 68.9 m USD | 52.5 m USD | 70.37 m USD |
| Operating profit | 25.84 m USD | -8.62 m USD | -5.39 m USD | 18.23 m USD | 13.56 m USD |
| Interest expense | 196 k USD | 56 k USD | 134 k USD | 105 k USD | 94 k USD |
| Profit before tax | 12.85 m USD | -8.49 m USD | -12.01 m USD | 14.99 m USD | 23.08 m USD |
| Income tax expense | 10.31 m USD | 3.35 m USD | -1.46 m USD | 1.31 m USD | 7.08 m USD |
| Net income (reported basis) | 2.54 m USD | -11.84 m USD | -10.55 m USD | 13.67 m USD | 16 m USD |
| Net income attributable to owners of the parent | 2.85 m USD | -11.84 m USD | -10.55 m USD | — | — |
| Basic earnings per share | 0 USD/share | -0.02 USD/share | -0.02 USD/share | 0.02 USD/share | 0.03 USD/share |
| Diluted earnings per share | 0 USD/share | -0.02 USD/share | -0.02 USD/share | 0.02 USD/share | 0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.